Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.

Azenta posts strong revenue growth but remains unprofitable despite robust cash reserves.

Risk flags

• ●Sustained operating losses despite double-digit revenue growth raise concerns about the company’s ability to achieve lasting profitability. The $4.2 million operating loss and negative free cash flow of $5 million for the quarter indicate that cost structures remain high relative to revenue.
• ●Guidance for organic revenue growth is muted, with fiscal 2026 expected to be flat to up 1%. This suggests that the recent growth surge may not be sustainable, and future performance could stagnate without new drivers.
• ●The announcement omits detailed breakdowns by customer, product, or geography, and does not reconcile forward-looking non-GAAP measures to GAAP, limiting transparency and making it harder for investors to assess underlying business quality.
• ●Operating expenses increased 12% year over year, matching revenue growth and constraining margin improvement. Without a clear plan to control costs, margin expansion targets may be difficult to achieve.
• ●While the company repurchased $50 million in shares, this capital return does not offset the lack of underlying profitability. Share buybacks can support the stock price in the short term but are not a substitute for operational improvements.

Bottom line

Azenta’s Q3 2026 results show strong top-line growth across both core segments and a sizable cash reserve, but the company remains unprofitable with negative free cash flow. Management’s guidance for the full year is modest, with organic revenue growth expected to stall and margin gains dependent on tighter cost controls. The lack of detailed disclosures on customers, products, or reconciliation of non-GAAP guidance leaves some questions unanswered about the sustainability of performance. While the $50 million share repurchase signals confidence and provides near-term support, it does not address the fundamental challenge of turning revenue growth into consistent profits. Investors should focus on whether Azenta can translate its revenue momentum into positive operating leverage and free cash flow in the coming quarters. The most important takeaway is that revenue growth alone is not yet delivering bottom-line results.

Announcement summary

(NASDAQ:AZTA) Azenta, Inc. reported financial results for the third quarter ended June 30, 2026, with revenue from continuing operations of $161 million, up 12% year over year. Organic revenue increased 9% year over year, excluding a 1-percentage point impact from foreign exchange and a 3-percentage point impact from the acquisition of UK Biocentre Limited. Sample Management Solutions revenue was $88 million, up 14% year over year, and Multiomics revenue was $73 million, up 10% year over year. Adjusted EBITDA for continuing operations was $18.5 million, with an adjusted EBITDA margin of 11.4%. The company ended the quarter with $529 million in cash, cash equivalents, restricted cash, and marketable securities, and repurchased 2.3 million shares of common stock for $50.0 million under its 2025 Repurchase Program. The company projects total reported revenue from continuing operations for fiscal 2026 to range between $613 to $618 million, adjusted EBITDA to be in the range of $59 million to $62 million, and free cash flow to improve approximately 10% to 15% year-over-year. The company also expects total organic revenue for fiscal 2026 to range between flat to up 1% compared to fiscal 2025.

Disagree with this article?